Introduction of a Variant Classification System for Analysis of Genotype-Phenotype Relationships in Heritable Retinoblastoma

Constitutional haploinsufficiency of the <i>RB1</i> gene causes heritable retinoblastoma, a tumor predisposition syndrome. Patients with heritable retinoblastoma develop multiple retinoblastomas early in childhood and other extraocular tumors later in life. Constitutional pathogenic vari...

Full description

Bibliographic Details
Main Authors: Isabel Hülsenbeck, Mirjam Frank, Eva Biewald, Deniz Kanber, Dietmar R. Lohmann, Petra Ketteler
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
pRB
Online Access:https://www.mdpi.com/2072-6694/13/7/1605
Description
Summary:Constitutional haploinsufficiency of the <i>RB1</i> gene causes heritable retinoblastoma, a tumor predisposition syndrome. Patients with heritable retinoblastoma develop multiple retinoblastomas early in childhood and other extraocular tumors later in life. Constitutional pathogenic variants in <i>RB1</i> are heterogeneous, and a few genotype-phenotype correlations have been described. To identify further genotype-phenotype relationships, we developed the retinoblastoma variant effect classification (REC), which considers each variant’s predicted effects on the common causal mediator, <i>RB1</i> protein pRB. For validation, the <i>RB1</i> variants of 287 patients were grouped according to REC. Multiple aspects of phenotypic expression were analyzed, known genotype-phenotype associations were revised, and new relationships were explored. Phenotypic expression of patients with REC-I, -II, and -III was distinct. Remarkably, the phenotype of patients with variants causing residual amounts of truncated pRB (REC-I) was more severe than patients with complete loss of <i>RB1</i> (REC-II). The age of diagnosis of REC-I variants appeared to be distinct depending on truncation’s localization relative to pRB structure domains. REC classes identify genotype-phenotype relationships and, therefore, this classification framework may serve as a tool to develop tailored tumor screening programs depending on the type of <i>RB1</i> variant.
ISSN:2072-6694